Market Update: Regeneron, UPS, and Zebra
Regeneron (REGN) has seen the end of its bear phase, with shares rising 12% to over $650 after reporting a 0.8% increase in revenue to $3.75 billion.
The company posted strong sales of Dupixent, at $4.9 billion, which offset weak sales from EYLEA. However, EYLEA HD sales grew by 42% to $663 million.
- Regeneron lowered its R&D and SG&A expense forecast for the fiscal year to manage costs.
- UPS added 8.0% after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion, despite being down nearly 25% in 2025.
- UPS announced a massive 48,000 job cut, with 34,000 job cuts in the operational unit and 14,000 roles cut at the management level.
- Zebra (ZBRA) continued to decline on stock markets, with its downtrend beginning in August and accelerating in October, resulting in an 11% loss.
No specific quotes are available in the given text.
Author's summary: Regeneron and UPS see gains after reporting earnings.